# Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/omalizumab-treatment-in-adolescents-with-chronic-spontaneous-urticaria-efficacy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Melike Ocak,Özge Soyer,Betül Büyüktiryaki,Bülent Enis Şekerel,Ümit Murat Şahiner |
| Citations | 16 |
| DOI | 10.1016/j.aller.2020.03.011 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.aller.2020.03.011 |
| OpenAlex ID | https://openalex.org/W3029088939 |
| PMID | 32467066 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Melike Ocak](https://scholariq.org/researchers/melike-ocak/)

## Paper journal

- [Allergologia et Immunopathologia](https://scholariq.org/journals/allergologia-et-immunopathologia/)

## Paper primary topic

- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

## Paper topics

- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.